Electroencephalogram (EEG) with or without transcranial magnetic stimulation (TMS) as biomarkers for post-stroke recovery: a narrative review
Stroke is one of the leading causes of death and disability. Despite the high prevalence of
stroke, characterizing the acute neural recovery patterns that follow stroke and predicting …
stroke, characterizing the acute neural recovery patterns that follow stroke and predicting …
[HTML][HTML] Recent advances in Lewy body dementia: A comprehensive review
Abstract Lewy Body Dementia is the second most frequent neurodegenerative illness
proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly …
proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly …
Lewy body dementias: a coin with two sides?
Á Milán-Tomás, M Fernández-Matarrubia… - Behavioral …, 2021 - mdpi.com
Lewy body dementias (LBDs) consist of dementia with Lewy bodies (DLB) and Parkinson's
disease dementia (PDD), which are clinically similar syndromes that share …
disease dementia (PDD), which are clinically similar syndromes that share …
A systematic literature review of fMRI and EEG resting-state functional connectivity in Dementia with Lewy Bodies: underlying mechanisms, clinical manifestation, and …
L Kucikova, H Kalabizadeh, KG Motsi, S Rashid… - Ageing Research …, 2023 - Elsevier
Previous studies suggest that there may be important links between functional connectivity,
disease mechanisms underpinning the Dementia with Lewy Body (DLB) and the key clinical …
disease mechanisms underpinning the Dementia with Lewy Body (DLB) and the key clinical …
Resting-state EEG measures cognitive impairment in Parkinson's disease
Cognitive dysfunction is common in Parkinson's disease (PD). We developed and evaluated
an EEG-based biomarker to index cognitive functions in PD from a few minutes of resting …
an EEG-based biomarker to index cognitive functions in PD from a few minutes of resting …
[HTML][HTML] Investigating Cortical Complexity in Mixed Dementia through Nonlinear Dynamic Analyses: A Resting-State EEG Study
H Pallathadka, ZR Gardanova… - Iranian Journal of …, 2024 - ncbi.nlm.nih.gov
Objective: Dementia is a broad term referring to a decline in problem-solving abilities,
language skills, memory, and other cognitive functions to a degree that it significantly …
language skills, memory, and other cognitive functions to a degree that it significantly …
[HTML][HTML] A deep learning model for the detection of various dementia and MCI pathologies based on resting-state electroencephalography data: A retrospective …
Y Watanabe, Y Miyazaki, M Hata, R Fukuma, Y Aoki… - Neural Networks, 2024 - Elsevier
Dementia and mild cognitive impairment (MCI) represent significant health challenges in an
aging population. As the search for noninvasive, precise and accessible diagnostic methods …
aging population. As the search for noninvasive, precise and accessible diagnostic methods …
Differential changes in visual and auditory event-related oscillations in dementia with Lewy bodies
Objective Aside from the cognitive impairment, patients with dementia with Lewy bodies
(DLB) have a high frequency of visual hallucinations and a number of other vision-related …
(DLB) have a high frequency of visual hallucinations and a number of other vision-related …
EEG Functional Connectivity Differences Predict Future Conversion to Dementia in Mild Cognitive Impairment With Lewy Body or Alzheimer Disease
J Hasoon, CA Hamilton, J Schumacher… - … Journal of Geriatric …, 2024 - Wiley Online Library
Background Predicting which individuals may convert to dementia from mild cognitive
impairment (MCI) remains difficult in clinical practice. Electroencephalography (EEG) is a …
impairment (MCI) remains difficult in clinical practice. Electroencephalography (EEG) is a …
[HTML][HTML] Lewy body dementias: controversies and drug development
Lewy body dementia (LBD) is one of the most common neurodegenerative dementias.
Clinical trials for symptomatic and disease-modifying therapies in LBD remain a national …
Clinical trials for symptomatic and disease-modifying therapies in LBD remain a national …